Home/Filings/4/0001209191-21-061281
4//SEC Filing

Leaman John Harold 4

Accession 0001209191-21-061281

CIK 0001445499other

Filed

Oct 20, 8:00 PM ET

Accepted

Oct 21, 5:31 PM ET

Size

5.5 KB

Accession

0001209191-21-061281

Insider Transaction Report

Form 4
Period: 2021-10-19
Leaman John Harold
Chief Financial Officer
Transactions
  • Award

    Restricted Stock Units (RSUs)

    2021-10-19+10,57110,571 total
    Exp: 2031-10-19Common Stock (10,571 underlying)
Footnotes (2)
  • [F1]Each RSU represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
  • [F2]The RSUs vest as to 100% of the total shares on December 31, 2022, subject to the reporting person's continuation of employment on such vesting date.

Issuer

IMPEL NEUROPHARMA INC

CIK 0001445499

Entity typeother

Related Parties

1
  • filerCIK 0001586657

Filing Metadata

Form type
4
Filed
Oct 20, 8:00 PM ET
Accepted
Oct 21, 5:31 PM ET
Size
5.5 KB